TAO Synergies Inc. Files 8-K with Executive Changes
Ticker: TAOX · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1571934
| Field | Detail |
|---|---|
| Company | Tao Synergies Inc. (TAOX) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-changes, filing-update
TL;DR
TAO Synergies filed an 8-K detailing exec changes & corporate updates.
AI Summary
TAO Synergies Inc. announced on June 26, 2025, several key executive changes and compensatory arrangements. The company also reported amendments to its articles of incorporation and bylaws, alongside a Regulation FD disclosure and financial statements. This filing follows a period where the company was formerly known as Synaptogenix, Inc. and Neurotrope Bioscience, Inc.
Why It Matters
This 8-K filing indicates significant internal corporate actions, including executive appointments and potential changes to corporate governance, which could impact the company's strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Executive changes and amendments to corporate documents can signal shifts in strategy or internal dynamics that may carry inherent risks.
Key Players & Entities
- TAO Synergies Inc. (company) — Registrant
- Synaptogenix, Inc. (company) — Former company name
- NEUROTROPE BIOSCIENCE, INC. (company) — Former company name
- June 26, 2025 (date) — Date of earliest event reported
FAQ
What specific executive positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers', but does not specify the exact positions in the provided text.
What are the key items disclosed in this Form 8-K filing?
The key items disclosed are: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on June 26, 2025.
What were TAO Synergies Inc.'s previous names?
TAO Synergies Inc. was formerly known as Synaptogenix, Inc. and prior to that, NEUROTROPE BIOSCIENCE, INC.
What is the SIC code for TAO Synergies Inc.?
The Standard Industrial Classification (SIC) code for TAO Synergies Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding TAO Synergies Inc. (TAOX).